| Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid … CWM Ong, GB Migliori, M Raviglione, G MacGregor-Skinner, G Sotgiu, ... European Respiratory Journal 56 (4), 2020 | 180 | 2020 |
| A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients L Petrone, E Petruccioli, V Vanini, G Cuzzi, SN Fard, T Alonzi, C Castilletti, ... Clinical microbiology and infection 27 (2), 286. e7-286. e13, 2021 | 149 | 2021 |
| Immune therapy, or antiviral therapy, or both for COVID-19: a systematic review F Cantini, D Goletti, L Petrone, S Najafi Fard, L Niccoli, R Foti Drugs 80 (18), 1929-1946, 2020 | 123 | 2020 |
| Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial … G d'Ettorre, G Rossi, C Scagnolari, M Andreotti, N Giustini, S Serafino, ... Immunity, inflammation and disease 5 (3), 244-260, 2017 | 107 | 2017 |
| ImmunosuppressiveTherapies differently modulate Humoral-and T-cell-specific responses to COVID-19 mRNA vaccine in rheumatoid arthritis patients A Picchianti-Diamanti, A Aiello, B Laganà, C Agrati, C Castilletti, S Meschi, ... Frontiers in immunology 12, 740249, 2021 | 89 | 2021 |
| In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy L Petrone, E Petruccioli, T Alonzi, V Vanini, G Cuzzi, SN Fard, C Castilletti, ... Journal of Infection 82 (4), 58-66, 2021 | 53 | 2021 |
| Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients A Aiello, SN Fard, E Petruccioli, L Petrone, V Vanini, C Farroni, G Cuzzi, ... International Journal of Infectious Diseases 106, 338-347, 2021 | 51 | 2021 |
| Impact of high-dose multi-strain probiotic supplementation on neurocognitive performance and central nervous system immune activation of HIV-1 infected individuals G Ceccarelli, JM Brenchley, EN Cavallari, G Corano Scheri, M Fratino, ... Nutrients 9 (11), 1269, 2017 | 48 | 2017 |
| Modulation of tryptophan/serotonin pathway by probiotic supplementation in human immunodeficiency virus–positive patients: preliminary results of a new study approach G Corano Scheri, SN Fard, I Schietroma, A Mastrangelo, C Pinacchio, ... International Journal of Tryptophan Research 10, 1178646917710668, 2017 | 38 | 2017 |
| Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine C Agrati, C Castilletti, D Goletti, A Sacchi, V Bordoni, D Mariotti, S Notari, ... Scientific Reports 12 (1), 6687, 2022 | 34 | 2022 |
| Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy M Musso, F Di Gennaro, G Gualano, S Mosti, C Cerva, SN Fard, ... Infection 49, 1061-1064, 2021 | 30 | 2021 |
| Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection S Najafi-Fard, A Aiello, A Navarra, G Cuzzi, V Vanini, GB Migliori, ... International Journal of Infectious Diseases 130, S34-S42, 2023 | 29 | 2023 |
| Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection E Petruccioli, S Najafi Fard, A Navarra, L Petrone, V Vanini, G Cuzzi, ... Journal of translational medicine 19 (1), 272, 2021 | 26 | 2021 |
| Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences A Aiello, S Najafi-Fard, D Goletti Frontiers in immunology 14, 1244556, 2023 | 24 | 2023 |
| Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients S Najafi Fard, I Schietroma, G Corano Scheri, N Giustini, S Serafino, ... Clinics and Research in Hepatology and Gastroenterology, 1-11, 2017 | 24 | 2017 |
| Multi-omics approach to COVID-19: a domain-based literature review C Montaldo, F Messina, I Abbate, M Antonioli, V Bordoni, A Aiello, ... Journal of translational medicine 19, 1-18, 2021 | 21 | 2021 |
| Impact of prior influenza and pneumoccocal vaccines on humoral and cellular response to SARS-CoV-2 BNT162b2 vaccination V Puro, C Castilletti, C Agrati, D Goletti, S Leone, A Agresta, E Cimini, ... Vaccines 9 (6), 615, 2021 | 20 | 2021 |
| Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients SN Fard, I Schietroma, GC Scheri, N Giustini, S Serafino, EN Cavallari, ... Clinics and Research in Hepatology and Gastroenterology 42 (4), 319-329, 2018 | 18 | 2018 |
| Cysteamine with in vitro antiviral activity and immunomodulatory effects has the potential to be a repurposing drug candidate for COVID-19 therapy T Alonzi, A Aiello, L Petrone, S Najafi Fard, M D’Eletto, L Falasca, ... Cells 11 (1), 52, 2021 | 16 | 2021 |
| Seroprevalence of anti-HEV and HEV RNA among volunteer blood donors and patients with Hepatitis B and C in Iran H Keyvani, MS Shamabadi, S Najafifard, B Hajibeigi, F Fallahian, ... Bangladesh Liver Journal 1 (1), 34-37, 2009 | 16 | 2009 |
